CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 117 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,256,645 | +786.9% | 84,282 | +418.7% | 0.03% | +900.0% |
| Q1 2023 | $141,691 | +25.1% | 16,249 | -10.1% | 0.00% | 0.0% |
| Q4 2022 | $113,305 | +163.5% | 18,071 | +24.8% | 0.00% | +200.0% |
| Q2 2022 | $43,000 | -92.3% | 14,479 | -90.9% | 0.00% | -97.4% |
| Q2 2020 | $557,000 | +75.7% | 159,465 | -25.6% | 0.04% | +46.2% |
| Q1 2020 | $317,000 | +131.4% | 214,436 | +700.4% | 0.03% | +100.0% |
| Q3 2019 | $137,000 | -66.1% | 26,790 | -46.5% | 0.01% | -80.6% |
| Q3 2017 | $404,000 | +861.9% | 50,077 | +128.7% | 0.07% | +235.0% |
| Q3 2015 | $42,000 | – | 21,897 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |